In contrast, GLP-1 receptor agonists appear to offer important complementary benefits related to weight reduction, glycemic control, renal protection, and atherosclerotic cardiovascular risk reduction, although their direct role in established HF remains less certain [16, 20, 22, 47]
The LAAM GSH-CQDs are composed of N-doped conjugated sp 2 carbons with a size of about 3.2 nm, surrounded by ~22 sterically hindered amino acid groups arranged alternately up and down at the edges
Specifically, antioxidants can efficiently neutralize reactive oxygen and nitrogen species, significantly reducing the damage these harmful molecules cause to brain neurons, and ensuring the preservation of neuronal structural and functional integrity
It is generally recommended that patients stay on GLP-1 medications for at least 12 weeks